<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="2.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Parasitol.</journal-id>
<journal-title>Frontiers in Parasitology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Parasitol.</abbrev-journal-title>
<issn pub-type="epub">2813-2424</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fpara.2023.1242727</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Parasitology</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Macrophage metallothioneins participate in the antileishmanial activity of antimonials</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Vargas</surname>
<given-names>Deninson Alejandro</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1175326"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Gregory</surname>
<given-names>David J.</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Koren</surname>
<given-names>Roni Nitzan</given-names>
</name>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zilberstein</surname>
<given-names>Dan</given-names>
</name>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1233334"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Belew</surname>
<given-names>Ashton Trey</given-names>
</name>
<xref ref-type="aff" rid="aff5">
<sup>5</sup>
</xref>
<xref ref-type="aff" rid="aff6">
<sup>6</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1380276"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>El-Sayed</surname>
<given-names>Najib M.</given-names>
</name>
<xref ref-type="aff" rid="aff5">
<sup>5</sup>
</xref>
<xref ref-type="aff" rid="aff6">
<sup>6</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1367698"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>G&#xf3;mez</surname>
<given-names>Mar&#xed;a Adelaida</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>*</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/280889"/>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>Centro Internacional de Entrenamiento e Investigaciones M&#xe9;dicas (CIDEIM)</institution>, <addr-line>Cali</addr-line>, <country>Colombia</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>Universidad Icesi</institution>, <addr-line>Cali</addr-line>, <country>Colombia</country>
</aff>
<aff id="aff3">
<sup>3</sup>
<institution>Department of Environmental Health, Harvard T.H. Chan School of Public Health</institution>, <addr-line>Boston, MA</addr-line>, <country>United States</country>
</aff>
<aff id="aff4">
<sup>4</sup>
<institution>Faculty of Biology, Technion-Israel Institute of Technology</institution>, <addr-line>Haifa</addr-line>, <country>Israel</country>
</aff>
<aff id="aff5">
<sup>5</sup>
<institution>Department of Cell Biology and Molecular Genetics, University of Maryland</institution>, <addr-line>College Park, MD</addr-line>, <country>United States</country>
</aff>
<aff id="aff6">
<sup>6</sup>
<institution>Center for Bioinformatics and Computational Biology, University of Maryland</institution>, <addr-line>College Park, MD</addr-line>, <country>United States</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>Edited by: Suzanne McDermott, Seattle Children&#x2019;s Research Institute, United States</p>
</fn>
<fn fn-type="edited-by">
<p>Reviewed by: Joana Tavares, Universidade do Porto, Portugal; Garima Chouhan, Sharda University, India</p>
</fn>
<fn fn-type="corresp" id="fn001">
<p>*Correspondence: Mar&#xed;a Adelaida G&#xf3;mez, <email xlink:href="mailto:mgomez@cideim.org.co">mgomez@cideim.org.co</email>; <email xlink:href="mailto:maria.gomez35@u.icesi.edu.co">maria.gomez35@u.icesi.edu.co</email>
</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>04</day>
<month>10</month>
<year>2023</year>
</pub-date>
<pub-date pub-type="collection">
<year>2023</year>
</pub-date>
<volume>2</volume>
<elocation-id>1242727</elocation-id>
<history>
<date date-type="received">
<day>19</day>
<month>06</month>
<year>2023</year>
</date>
<date date-type="accepted">
<day>12</day>
<month>09</month>
<year>2023</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2023 Vargas, Gregory, Koren, Zilberstein, Belew, El-Sayed and G&#xf3;mez</copyright-statement>
<copyright-year>2023</copyright-year>
<copyright-holder>Vargas, Gregory, Koren, Zilberstein, Belew, El-Sayed and G&#xf3;mez</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<p>Host cell functions that participate in the pharmacokinetics and pharmacodynamics (PK/PD) of drugs against intracellular pathogen infections are critical for drug efficacy. In this study, we investigated whether macrophage mechanisms of xenobiotic detoxification contribute to the elimination of intracellular <italic>Leishmania</italic> upon exposure to pentavalent antimonials (Sb<sup>V</sup>). Primary macrophages from patients with cutaneous leishmaniasis (CL) (n=6) were exposed <italic>ex vivo</italic> to <italic>L. V. panamensis</italic> infection and Sb<sup>V</sup>, and transcriptomes were generated. Seven metallothionein (MT) genes, potent scavengers of heavy metals and central elements of the mammalian cell machinery for xenobiotic detoxification, were within the top 20 up-regulated genes. To functionally validate the participation of MTs in drug-mediated killing of intracellular <italic>Leishmania</italic>, tandem knockdown (KD) of MT2-A and MT1-E, MT1-F, and MT1-X was performed using a pan-MT shRNA approach in THP-1 cells. Parasite survival was unaffected in tandem-KD cells, as a consequence of strong transcriptional upregulation of MTs by infection and Sb<sup>V</sup>, overcoming the KD effect. Gene silencing of the metal transcription factor-1 (MTF-1) abrogated expression of MT1 and MT2-A genes, but not ZnT-1. Upon exposure to Sb<sup>V</sup>, intracellular survival of <italic>Leishmania</italic> in MTF-1<sup>KD</sup> cells was significantly enhanced. Results from this study highlight the participation of macrophage MTs in Sb-dependent parasite killing.</p>
</abstract>
<kwd-group>
<kwd>metallothioneins</kwd>
<kwd>metal transcription factor-1 (MTF-1)</kwd>
<kwd>
<italic>leishmania</italic>
</kwd>
<kwd>antimony</kwd>
<kwd>host-parasite interaction</kwd>
</kwd-group>
<counts>
<fig-count count="4"/>
<table-count count="0"/>
<equation-count count="0"/>
<ref-count count="59"/>
<page-count count="10"/>
<word-count count="3974"/>
</counts>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-in-acceptance</meta-name>
<meta-value>Molecular Cellular Parasitology</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<sec id="s1" sec-type="intro">
<title>Introduction</title>
<p>Cutaneous leishmaniasis (CL) is caused by the intracellular protozoan parasite <italic>Leishmania</italic>, and affects more than 1.2 million people annually (<xref ref-type="bibr" rid="B1">Alvar et&#xa0;al., 2012</xref>). CL is endemic throughout Central and South America, where control remains dependent on chemotherapy with pentavalent antimonials (Sb<sup>V</sup>). The high rates of treatment failure (as high as 30% in controlled clinical trials), toxicity, and the difficulties associated with access to these drugs limit this control strategy (<xref ref-type="bibr" rid="B46">Romero et&#xa0;al., 2001</xref>; <xref ref-type="bibr" rid="B11">Croft et&#xa0;al., 2006</xref>; <xref ref-type="bibr" rid="B5">Arevalo et&#xa0;al., 2007</xref>; <xref ref-type="bibr" rid="B18">Firdous et&#xa0;al., 2009</xref>; <xref ref-type="bibr" rid="B42">Oliveira et&#xa0;al., 2011</xref>; <xref ref-type="bibr" rid="B38">Monge-Maillo and L&#xf3;pez-V&#xe9;lez, 2013</xref>; <xref ref-type="bibr" rid="B52">Sundar and Chakravarty, 2015</xref>). The direct activity of antimicrobials against intracellular pathogens is dependent on drug internalization into host cells and on host cell processes that mediate drug metabolism (activation/inactivation). This constitutes a challenge for the design of new drugs and the optimization of existing ones, because host cells act as an additional barrier for drug exposure of the intracellular microbe.</p>
<p>Antimony (Sb) is a metalloid closely related to arsenic (As). Sb exposure induces stress responses leading to activation of mechanisms of redox balance control and metal/xenobiotic detoxification (<xref ref-type="bibr" rid="B10">Cousins, 1994</xref>; <xref ref-type="bibr" rid="B45">Roesijadi, 2000</xref>; <xref ref-type="bibr" rid="B30">Lima et&#xa0;al., 2010</xref>; <xref ref-type="bibr" rid="B9">Coelho et&#xa0;al., 2014</xref>). Thus, factors mediating these responses could modulate Sb bioavailability within host cells, impacting the intracellular pharmacokinetics and pharmacodynamics (PK/PD) of these drugs. Illustrating this is evidence of the participation of macrophage ABC transporters in antileishmanial drug effects: Sb modulates the expression of macrophage ATP Binding Cassette (ABC) transporters (<xref ref-type="bibr" rid="B19">G&#xf3;mez et&#xa0;al., 2014</xref>; <xref ref-type="bibr" rid="B7">Barrera et&#xa0;al., 2017</xref>). ABCC1, ABCB1 and ABCB5 have been shown to function as Sb efflux pumps in <italic>L. donovani </italic>(<xref ref-type="bibr" rid="B39">Mookerjee Basu et&#xa0;al., 2008</xref>) and <italic>L.V. braziliensis</italic> infected macrophages (<xref ref-type="bibr" rid="B53">T&#xe9;llez et&#xa0;al., 2017</xref>), favoring intracellular parasite survival. ABCB6 can function as a plasma membrane Sb efflux transporter and as an intracellular Sb importer, potentially increasing drug concentrations within the phagolysosome, favoring intracellular <italic>L.V. panamensis</italic> killing (<xref ref-type="bibr" rid="B19">G&#xf3;mez et&#xa0;al., 2014</xref>).</p>
<p>Expression of other metal stress responsive genes is also modulated upon Sb exposure (<xref ref-type="bibr" rid="B19">G&#xf3;mez et&#xa0;al., 2014</xref>; <xref ref-type="bibr" rid="B53">T&#xe9;llez et&#xa0;al., 2017</xref>). Among these is metallothionein 2A (MT2-A), a small cysteine-rich cytoplasmic protein involved in zinc homeostasis and the scavenging of metals and electrophilic molecules such as reactive oxygen species (ROS) and nitric oxide (NO) (<xref ref-type="bibr" rid="B41">Nielson et&#xa0;al., 1985</xref>; <xref ref-type="bibr" rid="B54">Thornalley and Va&#x161;&#xe1;k, 1985</xref>; <xref ref-type="bibr" rid="B21">Hamer, 1986</xref>; <xref ref-type="bibr" rid="B3">Andrews, 2000</xref>; <xref ref-type="bibr" rid="B43">Park et&#xa0;al., 2001</xref>; <xref ref-type="bibr" rid="B57">Va&#x161;&#xe1;k and Meloni, 2011</xref>). There are four MT families (MT1-4): MT1 and MT2 are ubiquitously expressed, whereas MT3 and MT4 are found in the central nervous system and in stratified squamous epithelium, respectively (<xref ref-type="bibr" rid="B21">Hamer, 1986</xref>; <xref ref-type="bibr" rid="B40">Namdarghanbari et&#xa0;al., 2011</xref>). MTs can bind toxic metals with high affinity such as Cd, Hg, Pd, Ag, As, and Sb (<xref ref-type="bibr" rid="B41">Nielson et&#xa0;al., 1985</xref>), resulting in toxic metal tolerance and detoxification (<xref ref-type="bibr" rid="B49">Satoh et&#xa0;al., 1997</xref>; <xref ref-type="bibr" rid="B43">Park et&#xa0;al., 2001</xref>; <xref ref-type="bibr" rid="B40">Namdarghanbari et&#xa0;al., 2011</xref>). This efficient metal scavenging function results from the high thiol content of MTs and the tight regulation of MTs gene expression, which can increase more than 100 fold under metal stress, reaching intracellular protein concentrations of the order of millimolar (<xref ref-type="bibr" rid="B15">Durnam and Palmiter, 1981</xref>; <xref ref-type="bibr" rid="B21">Hamer, 1986</xref>; <xref ref-type="bibr" rid="B40">Namdarghanbari et&#xa0;al., 2011</xref>).</p>
<p>Our group and others have provided evidence for the participation of host MTs in the <italic>Leishmania-</italic>macrophage interactions: a) <italic>Leishmania</italic> infection and Sb<sup>V</sup> can strongly induce the expression of MT2-A in human macrophages (<xref ref-type="bibr" rid="B20">Gregory et&#xa0;al., 2008</xref>; <xref ref-type="bibr" rid="B19">G&#xf3;mez et&#xa0;al., 2014</xref>; <xref ref-type="bibr" rid="B17">Fernandes et&#xa0;al., 2016</xref>); b) an inverse correlation of MT2-A gene expression and intracellular survival of <italic>Leishmania</italic> during <italic>in vitro</italic> Sb<sup>V</sup> exposure has been reported (<xref ref-type="bibr" rid="B19">G&#xf3;mez et&#xa0;al., 2014</xref>); c) an Sb-susceptible <italic>L. V</italic>. <italic>panamensis</italic> strain induced higher expression of macrophage MT2-A compared with its Sb-resistant counterart, suggesting strain-specific manipulation of MT2-A expression within macrophages (<xref ref-type="bibr" rid="B7">Barrera et&#xa0;al., 2017</xref>). However, the role of MTs in their response to antimony and their relationship to antileishmanial drug effects and intracellular parasite survival remains unknown. Based on the above, we sought to dissect and functionally validate the participation of MTs in the Sb-mediated killing of intracellular <italic>Leishmania</italic>.</p>
</sec>
<sec id="s2" sec-type="materials|methods">
<title>Materials and methods</title>
<sec id="s2_1">
<title>Ethics statement</title>
<p>This study was approved and monitored by the institutional review board for ethical conduct of research involving human subjects of the Centro Internacional de Entrenamiento e Investigaciones M&#xe9;dicas - CIDEIM, in accordance with national (resolution 008430, Rep&#xfa;blica de Colombia, Ministry of Health, 1993) and international (Declaration of Helsinki and amendments, World Medical Association, Fortaleza, Brazil, October 2013) guidelines. All individuals voluntarily participated in the study and written informed consent was obtained from each participant.</p>
</sec>
<sec id="s2_2">
<title>Reagents and chemicals</title>
<p>Additive-free meglumine antimoniate (MA) (Walter Reed 214975AK; lot no. BLO918690-278-1A1W601) was kindly provided by the Walter Reed Army Institute, Silver Spring, MD, USA. Phorbol-12-myristate 13-acetate was purchased from Sigma&#x2013;Aldrich and zinc acetate dihydrate from J.T. Baker.</p>
</sec>
<sec id="s2_3">
<title>Subjects</title>
<p>Six adult patients, 18 to 65 years of age, with parasitological diagnosis of CL and time of lesion evolution &lt;6 months, without apparent immune deficiencies (negative HIV test, no evidence of immunological disorder nor treatment with medication having immunomodulating effects), participated in this study. For <italic>in vitro</italic> primary macrophage differentiation, peripheral blood mononuclear cells (PBMCs) were obtained from study participants by separation using a Ficoll-Hypaque (Sigma-Aldrich) gradient.</p>
</sec>
<sec id="s2_4">
<title>THP1 and primary macrophage differentiation</title>
<p>The human pro-monocytic cell line THP-1 and derived lines were maintained at 1 x 10<sup>6</sup> (<xref ref-type="bibr" rid="B18">Firdous et&#xa0;al., 2009</xref>) cells/mL in RPMI 1640 supplemented with 10% heat inactivated FBS, 100 &#x3bc;g/mL streptomycin, 100 U/mL penicillin, 5 &#xb5;g/mL puromycin (only for maintenance of transfected cells lines), at 37&#xb0;C and 5% CO<sub>2</sub>. THP-1 monocytes were differentiated with 250 ng/mL of PMA for 3 hours, washed twice with D-PBS and cultured 24h in 6 well plates. Human PBMC-derived monocytes were differentiated to macrophages by adherence to cell culture plastic-ware as previously described (<xref ref-type="bibr" rid="B13">Dohmen et&#xa0;al., 2016</xref>).</p>
</sec>
<sec id="s2_5">
<title>Parasites, infection and intracellular parasite survival assays</title>
<p>Antimony susceptible <italic>L. (V.) panamensis</italic> promastigotes (MHOM/CO/2002/3594) were kept at 25&#xb0;C in RPMI supplemented with 10% heat-inactivated FBS, 100 &#x3bc;g/mL streptomycin, 100 U/mL penicillin. Primary human macrophages and differentiated THP-1 cells were infected with human AB+ serum-opsonized stationary phase promastigotes at 10:1 <italic>Leishmania</italic>-macrophage ratio for 2h, washed twice with D-PBS and incubated for 24h at 34&#xb0;C, 5% CO<sub>2</sub>. After infection was established, cells were exposed for 24h or 48h to MA (8, 16, and 32 &#x3bc;g/mL), or left untreated as a control. Intracellular parasite survival was measured by RT-qPCR as previously described (<xref ref-type="bibr" rid="B47">Romero et&#xa0;al., 2010</xref>) (primers used in <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Table S1</bold>
</xref>).</p>
</sec>
<sec id="s2_6">
<title>RNA isolation, cDNA library preparation, and sequence analyses</title>
<p>Total RNA was isolated with Trizol from uninfected, infected, and drug-treated macrophages. RNA quality was assessed with an Agilent 2100 Bioanalyzer using RNAnano chips (Agilent). RNA Integrity Number (RIN) &#x2265; 7 was considered acceptable to continue with library construction. Poly-A enriched libraries were generated from macrophage RNA extracts using the Illumina TruSeq Standard mRNA preparation kit and checked via the Bioanalyzer and quantitative PCR (KAPA Biosystems). Paired-end reads (100 nt) were obtained using the Illumina HiSeq 1500 (BioProject ID <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/bioproject/?term=PRJNA633893">PRJNA633893</ext-link>, <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Table S2</bold>
</xref>). Fastqc [<xref ref-type="bibr" rid="B4">Anon, (2020)</xref>] was used to evaluate sequencing quality; Trimmomatic (<xref ref-type="bibr" rid="B8">Bolger et&#xa0;al., 2014</xref>) filtered low-quality reads and trimmed bases when the mean quality score fell below a threshold phred score of 20. Reads were mapped against the human (<xref ref-type="bibr" rid="B36">Miga et&#xa0;al., 2014</xref>) (hg38) and <italic>L. V. panamensis</italic> (<xref ref-type="bibr" rid="B6">Aslett et&#xa0;al., 2010</xref>) genomes (v36ish) using tophat (<xref ref-type="bibr" rid="B55">Trapnell et&#xa0;al., 2012</xref>). HTSeq (<xref ref-type="bibr" rid="B2">Anders et&#xa0;al., 2015</xref>) was used to count reads mapping to each gene feature. The count tables were restricted to the set of protein coding genes and filtered to remove non-expressed and very weakly expressed genes. The remaining genes were assessed for significant outliers and batch effects by visualizations of normalized data. Library sizes and count densities were calculated on non-normalized data; pairwise correlation and distances, outlier detection, and principal component analysis (PCA) were performed on log<sub>2</sub>, cpm, quantile normalized data with and without accounting for batch in the model or surrogate estimation with sva (using svaseq or combat) (<xref ref-type="bibr" rid="B27">Leek et&#xa0;al., 2012</xref>). DESeq2 (<xref ref-type="bibr" rid="B33">Love et&#xa0;al., 2014</xref>) was used to perform differential expression analyses alongside a statistically uninformed basic method as a negative control (<xref ref-type="supplementary-material" rid="SF3">
<bold>Supplementary Table S3</bold>
</xref>). Differentially expressed genes were contrasted between control vs. infected and MA-treated primary human macrophages. Genes deemed significantly different according to DESeq2 (|log<sub>2</sub>FC| &gt; 1.0 and a FDR adjusted p-value &lt; 0.05) were passed to various ontology tools. Enrichment PPI network analysis was carried out using STRING 10.</p>
</sec>
<sec id="s2_7">
<title>Short hairpin RNA constructs</title>
<p>A lentivirus-based system was used for shRNA-mediated gene silencing in THP-1 monocytes as previously described (<xref ref-type="bibr" rid="B59">Zhou et&#xa0;al., 2012</xref>). At least two independent sets of oligonucleotide pairs for gene knockdown of human MTs and the transcription factor MTF-1 (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Table S4</bold>
</xref>) were synthesized and cloned into the pLKO.1-TCR vector (Addgene, Cambridge, MA, USA); the same vector was also used as an empty vector control. Lentiviral particles were generated by co-transfection of endotoxin-free hairpin-containing pLKO.1-TCR, psPAX2 and MD2.G (Addgene) into HEK-293T cells. FuGENE HD (Roche) was used as the transfection reagent. Lentivirus-containing cell supernatant was collected 4 days after transfection and subsequently used to transduce THP-1 monocytes in medium containing 10 mg/mL polybrene in a proportion 1:1. Transduced cells were selected under puromycin pressure (5 &#xb5;g/mL) for a minimum of 5 days. Gene knockdown was confirmed by RT&#x2013;qPCR using SYBR green (Applied Biosystems) and TaqMan&#xae; Gene Expression Assays (Applied Biosystems, <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Table 1</bold>
</xref>). shRNA transduction was confirmed by DNA sequencing.</p>
</sec>
<sec id="s2_8">
<title>Cytotoxicity assays</title>
<p>PMA-differentiated THP-1 cells and derived cell lines were exposed to a dose range (8 &#x3bc;g/mL &#x2013; 256 &#x3bc;g/mL) of MA for 72 hours. Cell viability was assessed by MTT assay (ATCC) (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure S1</bold>
</xref>).</p>
</sec>
<sec id="s2_9">
<title>Statistical analysis</title>
<p>Based on the distribution of the data, differences in gene expression were tested with one-way analysis of variance and Tukey&#x2019;s multiple comparisons test. Differences in variance for the remaining experiments were analyzed with unpaired <italic>t</italic> test. A significance level of <italic>p</italic> &#x2264; 0.05 was used for all statistical tests. Statistical analyses were performed using GraphPad Prism software (version 6).</p>
</sec>
</sec>
<sec id="s3" sec-type="results">
<title>Results</title>
<sec id="s3_1">
<title>Metallothioneins are within the top 20 macrophages transcripts up-regulated by <italic>Leishmania</italic> infection and exposure to Sb<sup>V</sup>
</title>
<p>Peripheral blood mononuclear cell (PBMC)-derived macrophages from CL patients (n=6) were infected <italic>ex vivo</italic> with <italic>L.V. panamensis</italic> and exposed to Sb<sup>V</sup> (32&#xb5;g-Sb/mL, as meglumine antimoniate - MA). Following RNA-seq data collection, a total of 16,841 transcripts were detected. Principal Component Analysis (PCA) showed separation between uninfected/untreated control macrophages and those infected with <italic>L.V. panamensis</italic> and exposed to MA (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1A</bold>
</xref>). After filtering the differential expression (DE) data by |logFC| &#x2265; 2 and <italic>p &#x2264; 0.05</italic>, a set of 217 transcripts remained, of which 111 were up-regulated and 106 down-regulated (<xref ref-type="supplementary-material" rid="SF3">
<bold>Supplementary Table 3</bold>
</xref>). Interestingly, among the top twenty up-regulated transcripts, seven were metallothionein genes: MT1-E, MT1-F, MT1-G, MT1-H, MT1-M, MT1-X and MT2-A (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1B</bold>
</xref>; <xref ref-type="supplementary-material" rid="SF3">
<bold>Supplementary Table 3</bold>
</xref>).</p>
<fig id="f1" position="float">
<label>Figure&#xa0;1</label>
<caption>
<p>PCA plot and network analysis of macrophage transcriptomes. <bold>(A)</bold> PCA plot of RNA-seq data of primary macrophages from CL patients (n=6), which were infected <italic>in vitro</italic> with <italic>L.V. panamensis</italic> (Lp) and exposed to MA (32&#xb5;g/mL Sb<sup>V</sup>) for 24 h (purple) or were left uninfected and untreated as controls (green). Ovals represents confidence Interval-CI: 90% and 95% respectively. Each symbol represents each donor. <bold>(B)</bold> STRING network analysis with a |logFC|cutoff &#x2265; &#xb1; 2 and adjusted <italic>p</italic> value &#x2264; 0.05 (up-regulated genes: red circle; down-regulated genes: blue circle). Confidence of interaction set at 0.7.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fpara-02-1242727-g001.tif"/>
</fig>
</sec>
<sec id="s3_2">
<title>Induction of MTs expression by zinc acetate enhances MA<italic>-</italic>mediated killing of <italic>Leishmania</italic>
</title>
<p>To discern how MTs participate in the activity of antimonials, THP-1 cells were exposed to Sb<sup>V</sup> and the expression of MT1-E, MT1-F, MT1-X, MT2-A, MT3 and MT4 was quantified (primer sequences available in <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Table 1</bold>
</xref>). Expression of MT1-X was the highest, peaking at 8-fold induction over untreated cells; followed by MT1-E, MT2-A and MT1-F (<xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2A</bold>
</xref>). MT3 and MT4 transcripts were not detected in macrophages.</p>
<fig id="f2" position="float">
<label>Figure&#xa0;2</label>
<caption>
<p>MTs are induced by zinc acetate and antimony. <bold>(A)</bold> Fold change gene expression of MTs in THP-1 cells exposed to sub-cytotoxic doses of Sb<sup>V</sup>. <bold>(B)</bold> Fold change gene expression of MT1-E, 1-F, 1-X and MT2-A in THP-1 cells exposed to increasing doses of zinc acetate. <bold>(C)</bold> <italic>L.V. panamensis</italic> survival (%) in THP-1 cells pre-treated with 400 &#xb5;M Zn-acetate for 24h and exposed to Sb<sup>V</sup> (8, 16 and 32 &#xb5;g/mL). THP-1 gene expression and parasite survival were quantified by RT-qPCR. Each experiment was run as 3 independent replicates. Data are shown as mean &#xb1; SD.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fpara-02-1242727-g002.tif"/>
</fig>
<p>We evaluated the effect of maximal induction of MTs in intracellular <italic>Leishmania</italic> survival. THP-1 cells were exposed to a dose range of 25 &#xb5;M to 400 &#xb5;M Zn acetate for 24h, and peak expression of MTs (&gt;100 fold) was observed with 400 &#xb5;M Zn acetate (<xref ref-type="bibr" rid="B40">Namdarghanbari et&#xa0;al., 2011</xref>) (<xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2B</bold>
</xref>). Therefore, THP-1 cells were pre-treated for 24h with 400 &#xb5;M Zn acetate, followed by <italic>L. V. panamensis</italic> infection for additional 24h, and exposed to increasing and non-cytotoxic concentrations of MA (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure 1</bold>
</xref>). Pre-treatment with Zn acetate increased over 40% the Sb-dependent intracellular elimination of <italic>L.V. panamensis</italic> (<xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2C</bold>
</xref>), supporting the contribution of MTs to this phenotype.</p>
</sec>
<sec id="s3_3">
<title>Strong transcriptional up-regulation of MTs abrogates shRNA silencing of MT genes</title>
<p>An initial assessment of the participation of MT2-A gene silencing on intracellular survival of <italic>Leishmania</italic> did not show any significant effect (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure S2</bold>
</xref>). This led us to hypothesize that a compensatory effect of other MTs maybe operating in our system. Taking advantage of the high sequence similarity of MT genes, an shRNA was constructed which targets the tandem knockdown -KD- (MT_tandem<sup>KD</sup>) of MT1 and MT2 family member genes (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3A</bold>
</xref>). Expression of MT1-E, 1F, 1X and MT2-A was efficiently silenced as shown in <xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3B</bold>
</xref>. To explore the phenotypic effects of MTs KD on intracellular parasite survival, MT_tandem<sup>KD</sup> cells were infected with <italic>L. V. panamensis</italic> and exposed to Sb<sup>V</sup>. Despite effective KD of MT genes, intracellular parasite survival remained unchanged compared to empty-vector transfected control cells (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3C</bold>
</xref>). Considering that expression of MT genes is strongly induced by <italic>Leishmania</italic> and Sb<sup>V</sup>, we questioned whether MTs knockdown was maintained during the experimental conditions (infection and drug exposure). Despite the efficient tandem KD of MTs at basal conditions, their strong transcriptional up-regulation during <italic>Leishmania</italic> and Sb<sup>V</sup> exposure overcame the shRNA-silencing effect (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3D</bold>
</xref>), explaining why parasite survival was similar in MT_tandem<sup>KD</sup> and empty-vector control cells.</p>
<fig id="f3" position="float">
<label>Figure&#xa0;3</label>
<caption>
<p>MTs tandem knockdown is abrogated by strong transcriptional up-regulation. <bold>(A)</bold> Sequence alignment of MT genes and MT_tandem<sup>KD</sup> oligo sequence showing the conserved region targeted for tandem shRNA. <bold>(B)</bold> Validation of the tandem KD shown by MTs gene expression in uninfected MT_tandem<sup>KD</sup> and empty-vector control cells. <bold>(C)</bold> Percentage of parasite survival in empty vector control and MT_tandem<sup>KD</sup> cells infected with <italic>L.V. panamensis</italic> and exposed to Sb<sup>V</sup> (8, 16 and 32 &#xb5;g/mL). <bold>(D)</bold> Fold change gene expression of MTs upon infection and exposure to Sb<sup>V</sup> (8, 16 and 32 &#xb5;g/mL) in empty vector control and MT_tandem<sup>KD</sup> cells. Gene expression and parasite survival were quantified by RT-qPCR.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fpara-02-1242727-g003.tif"/>
</fig>
</sec>
<sec id="s3_4">
<title>Expression of MTs is silenced by MTF-1<sup>KD</sup> and favors survival of intracellular <italic>Leishmania</italic>
</title>
<p>Metal transcription factor-1 (MTF-1) is the principal transcription factor regulating expression of MTs genes during metal-induced stress (<xref ref-type="bibr" rid="B22">Heuchel et&#xa0;al., 1994</xref>). We explored whether knockdown of MTF-1 could limit the transcriptional induction of MT genes in our experimental conditions. Using shRNA, the steady-state level of MTF-1 was knocked down by 50% (<xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4A</bold>
</xref>). Expression of MTs and <italic>slc30a1</italic> (ZnT1) in MTF-1<sup>KD</sup> cells was evaluated under basal conditions and upon infection with <italic>L.V. panamensis</italic> and exposure to Sb<sup>V</sup>. A slight reduction (ranging from 5% to 40%) of MT1 and MT2 genes expression was observed in uninfected and unstimulated MTF-1<sup>KD</sup> cells (<xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4B</bold>
</xref>). However, induction of MT1-E, F, X and MT2-A expression was completely repressed in <italic>L.V. panamensis</italic> infected cells subsequently exposed to Sb (<xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4C</bold>
</xref>). In the case of <italic>slc30a1</italic> expression, we observed no significant differences in its expression (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure S3</bold>
</xref>), suggesting that the effect of MTF-1<sup>KD</sup> on MT expression responds from a more specific mechanisms triggered by the presence of xenobiotic metals such as aSb.</p>
<fig id="f4" position="float">
<label>Figure&#xa0;4</label>
<caption>
<p>Induction of MTs is abolished by knockdown of MTF-1 favoring intracellular parasite survival. <bold>(A)</bold> Fold change gene expression of MTF-1 in empty vector control and MTF-1KD THP-1 cells. <bold>(B)</bold> Fold change gene expression of MTs in unstimulated or <bold>(C)</bold> infected and SbV (8, 16 and 32 &#xb5;g/mL) exposed MTF-1KD cells. <bold>(D)</bold> Percentage of intracellular L.V. panamensis survival after SbV exposure. Gene expression and parasite survival were quantified by RT-qPCR. Each experiment was run in 3 independent replicates. Mann-Whitney test was used for statistical analysis. Data are presented as mean values &#xb1; SD.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fpara-02-1242727-g004.tif"/>
</fig>
<p>MTF-1<sup>KD</sup> and empty vector control THP-1 cells were infected and exposed to Sb<sup>V</sup> (8 - 32 &#xb5;g/mL), and intracellular parasite survival measured by RT-qPCR. Sb-dependent parasite killing was efficient in empty-vector control cells, where parasite survival was below 50% for all Sb<sup>V</sup> doses tested (<xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4D</bold>
</xref>). In contrast, <italic>Leishmania</italic> survival after drug exposure significantly increased in MTF-1<sup>KD</sup> cells compared to empty vector control cells (<xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4D</bold>
</xref>), and was above 50% for all evaluated doses and up to 75% in the 8 &#xb5;g/mL Sb<sup>V</sup> dose. These data suggest that MTF-1<sup>KD</sup> favors intracellular survival of <italic>Leishmania</italic> by impairing MTs gene expression.</p>
</sec>
</sec>
<sec id="s4" sec-type="discussion">
<title>Discussion</title>
<p>Metallothioneins were initially reported in the early &#x2018;70s and characterized as cadmium binding proteins with a role in metal detoxification (<xref ref-type="bibr" rid="B25">Klaassen et&#xa0;al., 1999</xref>). Subsequent studies demonstrated that these proteins could also bind other metals including Sb (<xref ref-type="bibr" rid="B41">Nielson et&#xa0;al., 1985</xref>), leading to protection against metal-induced toxicity. Pentavalent antimonials continue to be first line treatment for leishmaniasis in many endemic countries (<xref ref-type="bibr" rid="B58">WHO, 2010</xref>). Despite more than 100 years of use, the mechanisms of action and of exposure of the intracellular parasite to the active drug (Sb<sup>III</sup>), remain poorly understood. Recently, the role of host cells in antimony metabolism and detoxification has gained increased attention due to their potential participation in treatment outcome, and as potential targets for optimization of drug exposure (<xref ref-type="bibr" rid="B19">G&#xf3;mez et&#xa0;al., 2014</xref>; <xref ref-type="bibr" rid="B7">Barrera et&#xa0;al., 2017</xref>; <xref ref-type="bibr" rid="B53">T&#xe9;llez et&#xa0;al., 2017</xref>). Here, we provide evidence for the participation of macrophage metallothioneins in the Sb-mediated killing of intracellular <italic>Leishmania.</italic>
</p>
<p>Studies in MT1/MT2-null mice have demonstrated increased toxicity of cisplatinum, Cd, Hg, Cu, Zn and As -a metalloid closely related to Sb- (<xref ref-type="bibr" rid="B34">Masters et&#xa0;al., 1994</xref>; <xref ref-type="bibr" rid="B49">Satoh et&#xa0;al., 1997</xref>; <xref ref-type="bibr" rid="B31">Liu et&#xa0;al., 2000</xref>; <xref ref-type="bibr" rid="B43">Park et&#xa0;al., 2001</xref>; <xref ref-type="bibr" rid="B16">Eddins et&#xa0;al., 2008</xref>). Concurring with these findings, tolerance to metal-induced hepato- and nephrotoxicity has been demonstrated in transgenic mice overexpressing MTs (<xref ref-type="bibr" rid="B23">Iszard et&#xa0;al., 1995</xref>; <xref ref-type="bibr" rid="B32">Liu et&#xa0;al., 1995</xref>; <xref ref-type="bibr" rid="B25">Klaassen et&#xa0;al., 1999</xref>). Although the precise mechanism by which MTs facilitate Sb-dependent killing of <italic>Leishmania</italic> remains to be determined, the metal scavenging function of MTs could promote Sb accumulation within infected macrophages. Interestingly, it has been shown that MTs translocate to lysosomes (<xref ref-type="bibr" rid="B37">Moffatt and Denizeau, 1997</xref>; <xref ref-type="bibr" rid="B25">Klaassen et&#xa0;al., 1999</xref>; <xref ref-type="bibr" rid="B48">Saboli&#x107; et&#xa0;al., 2010</xref>), suggesting that MT-Sb complexes could be found within lysosomes. <italic>Leishmania</italic> resides in phagolysosomal compartments within host cells. Therefore, as a consequence of the biological process of phagosome-to-phagolysosome maturation, fusion of MT-Sb containing lysosomes with <italic>Leishmania-</italic>containing phagosomes could result in enhanced exposure of the intracellular parasite to the drug.</p>
<p>Pentavalent antimonials are pro-drugs which need to be reduced to the trivalent active form to exert their antileishmanial activity (Sb<sup>V</sup>&#x2192;Sb<sup>III</sup>). MTs have an important function in the cellular redox balance due to their high thiol content (<xref ref-type="bibr" rid="B41">Nielson et&#xa0;al., 1985</xref>; <xref ref-type="bibr" rid="B54">Thornalley and Va&#x161;&#xe1;k, 1985</xref>; <xref ref-type="bibr" rid="B21">Hamer, 1986</xref>; <xref ref-type="bibr" rid="B3">Andrews, 2000</xref>; <xref ref-type="bibr" rid="B43">Park et&#xa0;al., 2001</xref>; <xref ref-type="bibr" rid="B57">Va&#x161;&#xe1;k and Meloni, 2011</xref>). Under stress conditions, the strong up-regulation of MTs gene expression results in a redox capacity that can surpass that of GSH (<xref ref-type="bibr" rid="B15">Durnam and Palmiter, 1981</xref>; <xref ref-type="bibr" rid="B21">Hamer, 1986</xref>; <xref ref-type="bibr" rid="B40">Namdarghanbari et&#xa0;al., 2011</xref>). High GSH content has been shown to promote Sb<sup>V</sup> to Sb<sup>III</sup> reduction in mammalian cells as well as in <italic>Leishmania (</italic>
<xref ref-type="bibr" rid="B35">Miekeley et&#xa0;al., 2002</xref>; <xref ref-type="bibr" rid="B14">Dos Santos Ferreira et&#xa0;al., 2003</xref>). Thus, MTs could participate in the reduction Sb<sup>V</sup> to Sb<sup>III</sup> favoring parasite elimination.</p>
<p>MTF-1 is the main transcription factor involved in MTs expression during metal stress responses, and partially during oxidative stress exposure/response (<xref ref-type="bibr" rid="B12">Dalton et&#xa0;al., 1999</xref>; <xref ref-type="bibr" rid="B3">Andrews, 2000</xref>; <xref ref-type="bibr" rid="B44">Pearce et&#xa0;al., 2000</xref>; <xref ref-type="bibr" rid="B50">St. Croix et&#xa0;al., 2002</xref>; <xref ref-type="bibr" rid="B51">Stitt et&#xa0;al., 2006</xref>). Our results and those of others demonstrate that MTF-1 knockout/knockdown efficiently abolishes cellular expression of MTs under metal and oxidative stress (<xref ref-type="bibr" rid="B22">Heuchel et&#xa0;al., 1994</xref>; <xref ref-type="bibr" rid="B3">Andrews, 2000</xref>; <xref ref-type="bibr" rid="B50">St. Croix et&#xa0;al., 2002</xref>). Although our data provide evidence that repression of MTs expression via MTF-1 gene knockdown promotes intracellular survival of <italic>Leishmania</italic> after exposure to Sb, we cannot rule out the intervention of other MTF-1 mediated mechanisms in the enhanced parasite survival, such as those involved in Zn transport (<xref ref-type="bibr" rid="B29">Lichtlen et&#xa0;al., 2001</xref>; <xref ref-type="bibr" rid="B26">Laity and Andrews, 2007</xref>; <xref ref-type="bibr" rid="B56">Troadec et&#xa0;al., 2010</xref>; <xref ref-type="bibr" rid="B28">Lichten et&#xa0;al., 2011</xref>; <xref ref-type="bibr" rid="B24">Kim et&#xa0;al., 2014</xref>). However, evaluation the effect of MTF-1 KD in the expression of <italic>slc30a1</italic> (gene coding for the zinc transporter ZnT1) known to be modulated by MTF-1, did not result in significant expression differences in control and MTF-1<sup>KD</sup> cells when infected and exposed to Sb. We hypothesize that the specific effect observed over MT genes responds to a xenobiotic metal-specific response, which is supported by four MTF-1 binding sites in MT promoter regions, making this transcription factor the primary transcriptional regulator of MT genes. As was the case of ZnT1, and likely other genes where MTF-1 has some transcriptional participation, other transcription factors could be compensating for their expression in absence of MTF-1. However this remains to be experimentally demonstrated.</p>
<p>Our results support a dual role of MTs in toxic as well as therapeutic metal binding, highlighting the potential to harness host cell redox and metal detoxification systems to enhance drug bioavailability and exposure targeted to intracellular pathogens. These findings enlighten interesting drug-related homeostatic processes occurring during treatment of intracellular microbe infections, whereby the same mechanism that promotes host protection to drug-induced toxicity, in this case against Sb-induced stress, can enhance the antimicrobial activity of the drug.</p>
</sec>
<sec id="s5" sec-type="data-availability">
<title>Data availability statement</title>
<p>The original contributions presented in the study are publicly available. This data can be found here: <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/bioproject/?term=PRJNA633893">https://www.ncbi.nlm.nih.gov/bioproject/?term=PRJNA633893</ext-link>.</p>
</sec>
<sec id="s6" sec-type="ethics-statement">
<title>Ethics statement</title>
<p>The studies involving humans were approved by Comit&#xe9; Institucional de &#xc9;tica de Investigaci&#xf3;n en Humanos - CIEIH CIDEIM. The studies were conducted in accordance with the local legislation and institutional requirements. The participants provided their written informed consent to participate in this study.</p>
</sec>
<sec id="s7" sec-type="author-contributions">
<title>Author contributions</title>
<p>All authors contributed equally to the design, discussion, review of results and approval of the final version of the manuscript. DV developed the entire experimental component. AB and NES performed RNA-seq and supported bioinformatics analysis. DG support the design and implementation of RNA interference assays using shRNA. All authors contributed to the article and approved the submitted version.</p>
</sec>
</body>
<back>
<sec id="s8" sec-type="funding-information">
<title>Funding</title>
<p>This work was supported in part by US National Institutes of Health (NIH) award numbers R01AI104823 and U19AI129910 (<ext-link ext-link-type="uri" xlink:href="https://www.niaid.nih.gov/">https://www.niaid.nih.gov/</ext-link>), and Wellcome Trust award 107595/Z/15/Z to MG. Ministerio de Ciencia, Tecnolog&#xed;a e Innovaci&#xf3;n &#x2013; Minciencias (code no. 222984368586). DV was supported by COLCIENCIAS DSc student award 647.</p>
</sec>
<ack>
<title>Acknowledgments</title>
<p>We gratefully acknowledge the patients and volunteers who participated in this study and the members of the Clinical Unit of CIDEIM in Cali and Tumaco for recruitment of participants and follow-up. This work was conducted in partial fulfillment of the requirements for the DSc degree in Biomedical Sciences of Universidad del Valle to DV.</p>
</ack>
<sec id="s9" sec-type="COI-statement">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec id="s10" sec-type="disclaimer">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<sec id="s11" sec-type="supplementary-material">
<title>Supplementary material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fpara.2023.1242727/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fpara.2023.1242727/full#supplementary-material</ext-link>
</p>
<supplementary-material xlink:href="DataSheet_1.docx" id="SM1" mimetype="application/vnd.openxmlformats-officedocument.wordprocessingml.document"/>
<supplementary-material xlink:href="Table_3.xlsx" id="SF3" mimetype="application/vnd.openxmlformats-officedocument.spreadsheetml.sheet"/>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Alvar</surname> <given-names>J.</given-names>
</name>
<name>
<surname>V&#xe9;lez</surname> <given-names>I. D.</given-names>
</name>
<name>
<surname>Bern</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Herrero</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Desjeux</surname> <given-names>P.</given-names>
</name>
<name>
<surname>Cano.</surname> <given-names>J.</given-names>
</name>
<etal/>
</person-group>. (<year>2012</year>). <article-title>Leishmaniasis worldwide and global estimates of its incidence</article-title>. <source>PloS One</source>  <volume>7</volume> (<issue>5</issue>), <elocation-id>e35671</elocation-id>. doi: <pub-id pub-id-type="doi">10.1371/journal.pone.0035671</pub-id>
</citation>
</ref>
<ref id="B2">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Anders</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Pyl</surname> <given-names>P. T.</given-names>
</name>
<name>
<surname>Huber</surname> <given-names>W.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>HTSeq-A Python framework to work with high-throughput sequencing data</article-title>. <source>Bioinformatics</source> <volume>31</volume>, <fpage>166</fpage>&#x2013;<lpage>169</lpage>. doi: <pub-id pub-id-type="doi">10.1093/bioinformatics/btu638</pub-id>
</citation>
</ref>
<ref id="B3">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Andrews</surname> <given-names>G. K.</given-names>
</name>
</person-group> (<year>2000</year>). <article-title>Regulation of metallothionein gene expression by oxidative stress and metal ions</article-title>. <source>Biochem. Pharmacol.</source> <volume>59</volume>, <fpage>95</fpage>&#x2013;<lpage>104</lpage>. doi: <pub-id pub-id-type="doi">10.1016/S0006-2952(99)00301-9</pub-id>
</citation>
</ref>
<ref id="B4">
<citation citation-type="web">
<person-group person-group-type="author">
<collab>Anon</collab>
</person-group> <source>Babraham Bioinformatics - FastQC A Quality Control tool for High Throughput Sequence Data</source>. Available at: <uri xlink:href="https://www.bioinformatics.babraham.ac.uk/projects/fastqc/">https://www.bioinformatics.babraham.ac.uk/projects/fastqc/</uri> <year>2020</year>.</citation>
</ref>
<ref id="B5">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Arevalo</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Ramirez</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Adaui</surname> <given-names>V.</given-names>
</name>
<name>
<surname>Zimic</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Tulliano</surname> <given-names>G.</given-names>
</name>
<name>
<surname>Miranda-Ver&#xe1;stegui</surname> <given-names>C.</given-names>
</name>
<etal/>
</person-group>. (<year>2007</year>). <article-title>Influence of leishmania (Viannia) species on the response to antimonial treatment in patients with american tegumentary leishmaniasis</article-title>. <source>J. Infect. Dis.</source> <volume>195</volume>, <fpage>1846</fpage>&#x2013;<lpage>1851</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1086/518041</pub-id>
</citation>
</ref>
<ref id="B6">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Aslett</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Aurrecoechea</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Berriman</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Brestelli</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Brunk</surname> <given-names>B. P.</given-names>
</name>
<name>
<surname>Carrington</surname> <given-names>M.</given-names>
</name>
<etal/>
</person-group>. (<year>2010</year>). <article-title>TriTrypDB: a functional genomic resource for the Trypanosomatidae</article-title>. <source>Nucleic Acids Res.</source> <volume>38</volume>, <fpage>D457</fpage>&#x2013;<lpage>D462</lpage>. doi: <pub-id pub-id-type="doi">10.1093/nar/gkp851</pub-id>
</citation>
</ref>
<ref id="B7">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Barrera</surname> <given-names>M. C.</given-names>
</name>
<name>
<surname>Rojas</surname> <given-names>L. J.</given-names>
</name>
<name>
<surname>Weiss</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Fernandez</surname> <given-names>O.</given-names>
</name>
<name>
<surname>McMahon-Pratt</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Saravia</surname> <given-names>N. G.</given-names>
</name>
<etal/>
</person-group>. (<year>2017</year>). <article-title>Profiling gene expression of antimony response genes in Leishmania (Viannia) panamensis and infected macrophages and its relationship with drug susceptibility</article-title>. <source>Acta Trop.</source> <volume>176</volume>, <fpage>355</fpage>&#x2013;<lpage>363</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.actatropica.2017.08.017</pub-id>
</citation>
</ref>
<ref id="B8">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bolger</surname> <given-names>A. M.</given-names>
</name>
<name>
<surname>Lohse</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Usadel</surname> <given-names>B.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>Trimmomatic: a flexible trimmer for Illumina sequence data</article-title>. <source>Bioinformatics</source> <volume>30</volume>, <fpage>2114</fpage>&#x2013;<lpage>2120</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/bioinformatics/btu170</pub-id>
</citation>
</ref>
<ref id="B9">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Coelho</surname> <given-names>D. R.</given-names>
</name>
<name>
<surname>Miranda</surname> <given-names>E. S.</given-names>
</name>
<name>
<surname>Saint&#x2019;Pierre</surname> <given-names>T. D.</given-names>
</name>
<name>
<surname>Paumgartten</surname> <given-names>F. J. R.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>Tissue distribution of residual antimony in rats treated with multiple doses of meglumine antimoniate</article-title>. <source>Mem Inst Oswaldo Cruz</source> <volume>109</volume>, <fpage>420</fpage>&#x2013;<lpage>427</lpage>. doi: <pub-id pub-id-type="doi">10.1590/0074-0276140030</pub-id>
</citation>
</ref>
<ref id="B10">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cousins</surname> <given-names>R. J.</given-names>
</name>
</person-group> (<year>1994</year>). <article-title>Metal elements and gene expression</article-title>. <source>Annu. Rev. Nutr.</source> <volume>14</volume>, <fpage>449</fpage>&#x2013;<lpage>469</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1146/annurev.nu.14.070194.002313</pub-id>
</citation>
</ref>
<ref id="B11">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Croft</surname> <given-names>S. L.</given-names>
</name>
<name>
<surname>Sundar</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Fairlamb</surname> <given-names>A. H.</given-names>
</name>
</person-group> (<year>2006</year>). <article-title>Drug resistance in leishmaniasis</article-title>. <source>Clin. Microbiol. Rev.</source> <volume>19</volume>, <fpage>111</fpage>&#x2013;<lpage>126</lpage>. doi: <pub-id pub-id-type="doi">10.1128/CMR.19.1.111-126.2006</pub-id>
</citation>
</ref>
<ref id="B12">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dalton</surname> <given-names>T. P.</given-names>
</name>
<name>
<surname>Shertzer</surname> <given-names>H. G.</given-names>
</name>
<name>
<surname>Puga</surname> <given-names>A.</given-names>
</name>
</person-group> (<year>1999</year>). <article-title>Regulation of gene expression by reactive oxygen</article-title>. <source>Annu. Rev. Pharmacol. Toxicol.</source> <volume>39</volume>, <fpage>67</fpage>&#x2013;<lpage>101</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1146/annurev.pharmtox.39.1.67?url_ver=Z39.88-2003&amp;rfr_dat=cr_pub=pubmed&amp;rfr_id=ori:rid:crossref.org&amp;journalCode=pharmtox</pub-id>
</citation>
</ref>
<ref id="B13">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dohmen</surname> <given-names>L. C. T.</given-names>
</name>
<name>
<surname>Navas</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Vargas</surname> <given-names>D. A.</given-names>
</name>
<name>
<surname>Gregory</surname> <given-names>D. J</given-names>
</name>
<name>
<surname>Kip</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Dorlo</surname> <given-names>T. P. C.</given-names>
</name>
<etal/>
</person-group>. (<year>2016</year>). <article-title>Functional validation of ABCA3 as a miltefosine transporter in human macrophages: Impact on intracellular survival of Leishmania (viannia) panamensis</article-title>. <source>J. Biol. Chem.</source> <volume>291</volume>, <fpage>9638</fpage>&#x2013;<lpage>9647</lpage>. doi: <pub-id pub-id-type="doi">10.1074/jbc.M115.688168</pub-id>
</citation>
</ref>
<ref id="B14">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dos Santos Ferreira</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Silveira Martins</surname> <given-names>P.</given-names>
</name>
<name>
<surname>Demicheli</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Brochu</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Ouellette</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Fr&#xe9;zard</surname> <given-names>F.</given-names>
</name>
</person-group> (<year>2003</year>). <article-title>Thiol-induced reduction of antimony(V) into antimony(III): A comparative study with trypanothione, cysteinyl-glycine, cysteine and glutathione</article-title>. <source>BioMetals</source> <volume>16</volume>, <fpage>441</fpage>&#x2013;<lpage>446</lpage>. doi: <pub-id pub-id-type="doi">10.1023/A:1022823605068</pub-id>
</citation>
</ref>
<ref id="B15">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Durnam</surname> <given-names>D. M.</given-names>
</name>
<name>
<surname>Palmiter</surname> <given-names>R. D.</given-names>
</name>
</person-group> (<year>1981</year>). <article-title>Transcriptional regulation of the mouse metallothionein-I gene by heavy metals</article-title>. <source>J. Biol. Chem.</source> <volume>256</volume>, <fpage>5712</fpage>&#x2013;<lpage>5716</lpage>. doi: <pub-id pub-id-type="doi">10.1016/S0021-9258(19)69264-1</pub-id>
</citation>
</ref>
<ref id="B16">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Eddins</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Petro</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Pollard</surname> <given-names>N.</given-names>
</name>
<name>
<surname>Freedman</surname> <given-names>J. H.</given-names>
</name>
<name>
<surname>Levin</surname> <given-names>E. D.</given-names>
</name>
</person-group> (<year>2008</year>). <article-title>Mercury-induced cognitive impairment in metallothionein-1/2 null mice</article-title>. <source>Neurotoxicol Teratol</source> <volume>30</volume>, <fpage>88</fpage>&#x2013;<lpage>95</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.ntt.2007.12.005</pub-id>
</citation>
</ref>
<ref id="B17">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fernandes</surname> <given-names>M. C.</given-names>
</name>
<name>
<surname>Dillon</surname> <given-names>L. A. L.</given-names>
</name>
<name>
<surname>Belew</surname> <given-names>A. T.</given-names>
</name>
<name>
<surname>Bravo</surname> <given-names>H. C.</given-names>
</name>
<name>
<surname>Mosser</surname> <given-names>D. M.</given-names>
</name>
<name>
<surname>El-Sayed</surname> <given-names>N. M.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>Dual transcriptome profiling of leishmania -infected human macrophages reveals distinct reprogramming signatures</article-title>. <source>MBio</source> <volume>7</volume>, <fpage>e00027</fpage>&#x2013;<lpage>e00016</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/mBio.00027-16</pub-id>
</citation>
</ref>
<ref id="B18">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Firdous</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Yasinzai</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Ranja</surname> <given-names>K.</given-names>
</name>
</person-group> (<year>2009</year>). <article-title>Efficacy of glucantime in the treatment of old world cutaneous leishmaniasis</article-title>. <source>Int. J. Dermatol.</source> <volume>48</volume>, <fpage>758</fpage>&#x2013;<lpage>762</lpage>. doi: <pub-id pub-id-type="doi">10.1111/j.1365-4632.2009.04072.x</pub-id>
</citation>
</ref>
<ref id="B19">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>G&#xf3;mez</surname> <given-names>M. A.</given-names>
</name>
<name>
<surname>Navas</surname> <given-names>A.</given-names>
</name>
<name>
<surname>M&#xe1;rquez</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Rojas</surname> <given-names>L. L.</given-names>
</name>
<name>
<surname>Vargas</surname> <given-names>D. A.</given-names>
</name>
<name>
<surname>Blanco</surname> <given-names>V. M.</given-names>
</name>
<etal/>
</person-group>. (<year>2014</year>). <article-title>Leishmania panamensis infection and antimonial drugs modulate expression of macrophage drug transporters and metabolizing enzymes: impact on intracellular parasite survival</article-title>. <source>J. Antimicrob. Chemother.</source> <volume>69</volume>, <fpage>139</fpage>&#x2013;<lpage>149</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/jac/dkt334</pub-id>
</citation>
</ref>
<ref id="B20">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gregory</surname> <given-names>D. J.</given-names>
</name>
<name>
<surname>Sladek</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Olivier</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Matlashewski</surname> <given-names>G.</given-names>
</name>
</person-group> (<year>2008</year>). <article-title>Comparison of the Effects of Leishmania major or Leishmania donovani Infection on Macrophage Gene Expression</article-title>. <source>Infect. Immun.</source> <volume>76</volume>, <fpage>1186</fpage>&#x2013;<lpage>1192</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/IAI.01320-07</pub-id>
</citation>
</ref>
<ref id="B21">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hamer</surname> <given-names>D. H.</given-names>
</name>
</person-group> (<year>1986</year>). <article-title>Metallothionein</article-title>. <source>Annu. Rev. Biochem.</source> <volume>55</volume>, <fpage>913</fpage>&#x2013;<lpage>951</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1146/annurev.bi.55.070186.004405</pub-id>
</citation>
</ref>
<ref id="B22">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Heuchel</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Radtke</surname> <given-names>F.</given-names>
</name>
<name>
<surname>Georgiev</surname> <given-names>O.</given-names>
</name>
<name>
<surname>Stark</surname> <given-names>G.</given-names>
</name>
<name>
<surname>Aguet</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Schaffner</surname> <given-names>W.</given-names>
</name>
</person-group> (<year>1994</year>). <article-title>The transcription factor MTF-1 is essential for basal and heavy metal-induced metallothionein gene expression</article-title>. <source>EMBO J.</source> <volume>13</volume>, <fpage>2870</fpage>&#x2013;<lpage>2875</lpage>. doi: <pub-id pub-id-type="doi">10.1002/j.1460-2075.1994.tb06581.x</pub-id>
</citation>
</ref>
<ref id="B23">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Iszard</surname> <given-names>M. B.</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>Y. P.</given-names>
</name>
<name>
<surname>Dalton</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Andrews</surname> <given-names>G. K.</given-names>
</name>
<name>
<surname>Palmiter</surname> <given-names>R. D.</given-names>
</name>
<etal/>
</person-group>. (<year>1995</year>). <article-title>Characterization of metallothionein-I-transgenic mice</article-title>. <source>Toxicol. Appl. Pharmacol.</source> <volume>133</volume>, <fpage>305</fpage>&#x2013;<lpage>312</lpage>. doi: <pub-id pub-id-type="doi">10.1006/taap.1995.1155</pub-id>
</citation>
</ref>
<ref id="B24">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname> <given-names>J. -H.</given-names>
</name>
<name>
<surname>Jeon</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Shin</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Won</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Lee</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Kwak</surname> <given-names>J. -S.</given-names>
</name>
<etal/>
</person-group>. (<year>2014</year>). <article-title>Regulation of the catabolic cascade in osteoarthritis by the zinc-ZIP8-MTF1 axis</article-title>. <source>Cell</source> <volume>156</volume>, <fpage>730</fpage>&#x2013;<lpage>743</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.cell.2014.01.007</pub-id>
</citation>
</ref>
<ref id="B25">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Klaassen</surname> <given-names>C. D.</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Choudhuri</surname> <given-names>S.</given-names>
</name>
</person-group> (<year>1999</year>). <article-title>METALLOTHIONEIN: an intracellular protein to protect against cadmium toxicity</article-title>. <source>Annu. Rev. Pharmacol. Toxicol.</source> <volume>39</volume>, <fpage>267</fpage>&#x2013;<lpage>294</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1146/annurev.pharmtox.39.1.267</pub-id>
</citation>
</ref>
<ref id="B26">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Laity</surname> <given-names>J. H.</given-names>
</name>
<name>
<surname>Andrews</surname> <given-names>G. K.</given-names>
</name>
</person-group> (<year>2007</year>). <article-title>Understanding the mechanisms of zinc-sensing by metal-response element binding transcription factor-1 (MTF-1)</article-title>. <source>Arch. Biochem. Biophys.</source> <volume>463</volume>, <fpage>201</fpage>&#x2013;<lpage>210</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.abb.2007.03.019</pub-id>
</citation>
</ref>
<ref id="B27">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Leek</surname> <given-names>J. T.</given-names>
</name>
<name>
<surname>Johnson</surname> <given-names>W. E.</given-names>
</name>
<name>
<surname>Parker</surname> <given-names>H. S.</given-names>
</name>
<name>
<surname>Jaffe</surname> <given-names>A. E.</given-names>
</name>
<name>
<surname>Storey</surname> <given-names>J. D.</given-names>
</name>
</person-group> (<year>2012</year>). <article-title>SVA detailed instruction</article-title>. <source>Bioinformatics</source> <volume>28</volume>, <fpage>882</fpage>&#x2013;<lpage>883</lpage>. doi: <pub-id pub-id-type="doi">10.1093/bioinformatics/bts034</pub-id>
</citation>
</ref>
<ref id="B28">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lichten</surname> <given-names>L. A.</given-names>
</name>
<name>
<surname>Ryu</surname> <given-names>M.-S.</given-names>
</name>
<name>
<surname>Guo</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Embury</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Cousins</surname> <given-names>R. J.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>MTF-1-mediated repression of the zinc transporter zip10 is alleviated by zinc restriction bryk M, ed</article-title>. <source>PloS One</source> <volume>6</volume>, <elocation-id>e21526</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1371/journal.pone.0021526</pub-id>
</citation>
</ref>
<ref id="B29">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lichtlen</surname> <given-names>P.</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Belser</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Georgiev</surname> <given-names>O.</given-names>
</name>
<name>
<surname>Certa</surname> <given-names>U.</given-names>
</name>
<name>
<surname>Sack</surname> <given-names>R.</given-names>
</name>
<etal/>
</person-group>. (<year>2001</year>). <article-title>Target gene search for the metal-responsive transcription factor MTF-1</article-title>. <source>Nucleic Acids Res.</source> <volume>29</volume>, <fpage>1514</fpage>&#x2013;<lpage>1523</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/nar/29.7.1514</pub-id>
</citation>
</ref>
<ref id="B30">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lima</surname> <given-names>M. I. S.</given-names>
</name>
<name>
<surname>Arruda</surname> <given-names>V. O.</given-names>
</name>
<name>
<surname>Alves</surname> <given-names>E. V. C.</given-names>
</name>
<name>
<surname>de Azevedo</surname> <given-names>A. P. S.</given-names>
</name>
<name>
<surname>Monteiro</surname> <given-names>S. G.</given-names>
</name>
<name>
<surname>Pereira</surname> <given-names>S. R. F.</given-names>
</name>
</person-group> (<year>2010</year>). <article-title>Genotoxic effects of the antileishmanial drug glucantime<sup>&#xae;</sup>
</article-title>. <source>Arch. Toxicol.</source> <volume>84</volume>, <fpage>227</fpage>&#x2013;<lpage>232</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s00204-009-0485-0</pub-id>
</citation>
</ref>
<ref id="B31">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Goyer</surname> <given-names>R. A.</given-names>
</name>
<name>
<surname>Achanzar</surname> <given-names>W.</given-names>
</name>
<name>
<surname>Waalkes</surname> <given-names>M. P.</given-names>
</name>
</person-group> (<year>2000</year>). <article-title>Metallothionein-I/II null mice are more sensitive than wild-type mice to the hepatotoxic and nephrotoxic effects of chronic oral or injected inorganic arsenicals</article-title>. <source>Toxicol. Sci.</source> <volume>55</volume>, <fpage>460</fpage>&#x2013;<lpage>467</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/toxsci/55.2.460</pub-id>
</citation>
</ref>
<ref id="B32">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname> <given-names>Y. P.</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Iszard</surname> <given-names>M. B.</given-names>
</name>
<name>
<surname>Andrews</surname> <given-names>G. K.</given-names>
</name>
<name>
<surname>Palmiter</surname> <given-names>R. D.</given-names>
</name>
<name>
<surname>Klaassen</surname> <given-names>C. D.</given-names>
</name>
</person-group> (<year>1995</year>). <article-title>Transgenic mice that overexpress metallothionein-I are protected from cadmium lethality and hepatotoxicity</article-title>. <source>Toxicol. Appl. Pharmacol.</source> <volume>135</volume>, <fpage>222</fpage>&#x2013;<lpage>228</lpage>. doi: <pub-id pub-id-type="doi">10.1006/taap.1995.1227</pub-id>
</citation>
</ref>
<ref id="B33">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Love</surname> <given-names>M. I.</given-names>
</name>
<name>
<surname>Huber</surname> <given-names>W.</given-names>
</name>
<name>
<surname>Anders</surname> <given-names>S.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2</article-title>. <source>Genome Biol.</source> <volume>15</volume>, <fpage>550</fpage>. doi: <pub-id pub-id-type="doi">10.1186/s13059-014-0550-8</pub-id>
</citation>
</ref>
<ref id="B34">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Masters</surname> <given-names>B. A.</given-names>
</name>
<name>
<surname>Kelly</surname> <given-names>E. J.</given-names>
</name>
<name>
<surname>Quaife</surname> <given-names>C. J.</given-names>
</name>
<name>
<surname>Brinster</surname> <given-names>R. L.</given-names>
</name>
<name>
<surname>Palmiter</surname> <given-names>R. D.</given-names>
</name>
</person-group> (<year>1994</year>). <article-title>Targeted disruption of metallothionein I and II genes increases sensitivity to cadmium</article-title>. <source>Proc. Natl. Acad. Sci.</source> <volume>91</volume>, <fpage>584</fpage>&#x2013;<lpage>588</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1073/pnas.91.2.584</pub-id>
</citation>
</ref>
<ref id="B35">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Miekeley</surname> <given-names>N.</given-names>
</name>
<name>
<surname>Mortari</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Schubach</surname> <given-names>A.</given-names>
</name>
</person-group> (<year>2002</year>). <article-title>Monitoring of total antimony and its species by ICP-MS and on-line ion chromatography in biological samples from patients treated for leishmaniasis</article-title>. <source>Anal. Bioanal Chem.</source> <volume>372</volume>, <fpage>495</fpage>&#x2013;<lpage>502</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s00216-001-1213-7</pub-id>
</citation>
</ref>
<ref id="B36">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Miga</surname> <given-names>K. H.</given-names>
</name>
<name>
<surname>Newton</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Jain</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Altemose</surname> <given-names>N.</given-names>
</name>
<name>
<surname>Willard</surname> <given-names>H. F.</given-names>
</name>
<name>
<surname>Kent</surname> <given-names>E. J.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>Centromere reference models for human chromosomes X and y satellite arrays</article-title>. <source>Genome Res.</source> <volume>24</volume>, <fpage>697</fpage>&#x2013;<lpage>707</lpage>. doi: <pub-id pub-id-type="doi">10.1101/gr.159624.113</pub-id>
</citation>
</ref>
<ref id="B37">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Moffatt</surname> <given-names>P.</given-names>
</name>
<name>
<surname>Denizeau</surname> <given-names>F.</given-names>
</name>
</person-group> (<year>1997</year>). <article-title>Metallothionein in physiological and physiopathological processes</article-title>. <source>Drug Metab. Rev.</source> <volume>29</volume>, <fpage>261</fpage>&#x2013;<lpage>307</lpage>. doi: <pub-id pub-id-type="doi">10.3109/03602539709037585</pub-id>
</citation>
</ref>
<ref id="B38">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Monge-Maillo</surname> <given-names>B.</given-names>
</name>
<name>
<surname>L&#xf3;pez-V&#xe9;lez</surname> <given-names>R.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>Therapeutic options for old world cutaneous leishmaniasis and new world cutaneous and mucocutaneous leishmaniasis</article-title>. <source>Drugs</source> <volume>73</volume>, <fpage>1889</fpage>&#x2013;<lpage>1920</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s40265-013-0132-1</pub-id>
</citation>
</ref>
<ref id="B39">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mookerjee Basu</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Mookerjee</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Banerjee</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Saha</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Singh</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Naskar</surname> <given-names>K.</given-names>
</name>
<etal/>
</person-group>. (<year>2008</year>). <article-title>Inhibition of ABC transporters abolishes antimony resistance in leishmania infection</article-title>. <source>Antimicrob. Agents Chemother.</source> <volume>52</volume>, <fpage>1080</fpage>&#x2013;<lpage>1093</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/AAC.01196-07</pub-id>
</citation>
</ref>
<ref id="B40">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Namdarghanbari</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Wobig</surname> <given-names>W.</given-names>
</name>
<name>
<surname>Krezoski</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Tabatabai</surname> <given-names>N. M.</given-names>
</name>
<name>
<surname>Petering</surname> <given-names>D. H.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>Mammalian metallothionein in toxicology, cancer, and cancer chemotherapy</article-title>. <source>JBIC J. Biol. Inorg Chem.</source> <volume>16</volume>, <fpage>1087</fpage>&#x2013;<lpage>1101</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s00775-011-0823-6</pub-id>
</citation>
</ref>
<ref id="B41">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nielson</surname> <given-names>K. B.</given-names>
</name>
<name>
<surname>Atkin</surname> <given-names>C. L.</given-names>
</name>
<name>
<surname>Winge</surname> <given-names>D. R.</given-names>
</name>
</person-group> (<year>1985</year>). <article-title>Distinct metal-binding configurations in metallothionein</article-title>. <source>J. Biol. Chem.</source> <volume>260</volume>, <fpage>5342</fpage>&#x2013;<lpage>5350</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1021/bi00079a028</pub-id>
</citation>
</ref>
<ref id="B42">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Oliveira</surname> <given-names>L. F.</given-names>
</name>
<name>
<surname>Schubach</surname> <given-names>A. O.</given-names>
</name>
<name>
<surname>Martins</surname> <given-names>M. M.</given-names>
</name>
<name>
<surname>Passos</surname> <given-names>S. L.</given-names>
</name>
<name>
<surname>Oliveira</surname> <given-names>R. V.</given-names>
</name>
<name>
<surname>Marzochi</surname> <given-names>M. C.</given-names>
</name>
<etal/>
</person-group>. (<year>2011</year>). <article-title>Systematic review of the adverse effects of cutaneous leishmaniasis treatment in the New World</article-title>. <source>Acta Trop.</source> <volume>118</volume>, <fpage>87</fpage>&#x2013;<lpage>96</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.actatropica.2011.02.007</pub-id>
</citation>
</ref>
<ref id="B43">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Park</surname> <given-names>J. D.</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Klaassen</surname> <given-names>C. D.</given-names>
</name>
</person-group> (<year>2001</year>). <article-title>Protective effect of metallothionein against the toxicity of cadmium and other metals</article-title>. <source>Toxicology</source> <volume>163</volume>, <fpage>93</fpage>&#x2013;<lpage>100</lpage>. doi: <pub-id pub-id-type="doi">10.1016/S0300-483X(01)00375-4</pub-id>
</citation>
</ref>
<ref id="B44">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pearce</surname> <given-names>L. L.</given-names>
</name>
<name>
<surname>Gandley</surname> <given-names>R. E.</given-names>
</name>
<name>
<surname>Han</surname> <given-names>W.</given-names>
</name>
<name>
<surname>Wasserloos</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Stitt</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Kanai</surname> <given-names>A. J.</given-names>
</name>
<etal/>
</person-group>. (<year>2000</year>). <article-title>Role of metallothionein in nitric oxide signaling as revealed by a green fluorescent fusion protein</article-title>. <source>Proc. Natl. Acad. Sci. U.S.A.</source> <volume>97</volume>, <fpage>477</fpage>&#x2013;<lpage>482</lpage>. doi: <pub-id pub-id-type="doi">10.1073/pnas.97.1.477</pub-id>
</citation>
</ref>
<ref id="B45">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Roesijadi</surname> <given-names>G.</given-names>
</name>
</person-group> (<year>2000</year>). <article-title>Metal transfer as a mechanism for metallothionein-mediated metal detoxification</article-title>. <source>Cell Mol. Biol. (Noisy-le-grand)</source> <volume>46</volume>, <fpage>393</fpage>&#x2013;<lpage>405</lpage>.</citation>
</ref>
<ref id="B46">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Romero</surname> <given-names>G. A. S.</given-names>
</name>
<name>
<surname>de Farias Guerra</surname> <given-names>M. V.</given-names>
</name>
<name>
<surname>Paes</surname> <given-names>M. G.</given-names>
</name>
<name>
<surname>Macedo V d.</surname> <given-names>O.</given-names>
</name>
</person-group> (<year>2001</year>). <article-title>Comparison of Cutaneous Leishmaniasis Due to Leishmania (Viannia) Braziliensis and L. (V.) guyanensis in Brazil: Clinical Findings and Diagnostic Approach</article-title>. <source>Clin. Infect. Dis.</source> <volume>32</volume>, <fpage>1304</fpage>&#x2013;<lpage>1312</lpage>. doi: <pub-id pub-id-type="doi">10.1086/319990</pub-id>
</citation>
</ref>
<ref id="B47">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Romero</surname> <given-names>I.</given-names>
</name>
<name>
<surname>T&#xe9;llez</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Su&#xe1;rez</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Cardona</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Figueroa</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Zelazny</surname> <given-names>A.</given-names>
</name>
<etal/>
</person-group>. (<year>2010</year>). <article-title>Viability and Burden of Leishmania in Extralesional Sites during Human Dermal Leishmaniasis Milon G, ed</article-title>. <source>PloS Negl. Trop. Dis.</source> <volume>4</volume>, <fpage>e819</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1371/journal.pntd.0000819</pub-id>
</citation>
</ref>
<ref id="B48">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Saboli&#x107;</surname> <given-names>I.</given-names>
</name>
<name>
<surname>Breljak</surname> <given-names>D.</given-names>
</name>
<name>
<surname>&#x160;karica</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Herak-Kramberger</surname> <given-names>C. M.</given-names>
</name>
</person-group> (<year>2010</year>). <article-title>Role of metallothionein in cadmium traffic and toxicity in kidneys and other mammalian organs</article-title>. <source>BioMetals</source> <volume>23</volume>, <fpage>897</fpage>&#x2013;<lpage>926</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s10534-010-9351-z</pub-id>
</citation>
</ref>
<ref id="B49">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Satoh</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Aoki</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Tohyama</surname> <given-names>C.</given-names>
</name>
</person-group> (<year>1997</year>). <article-title>Protective role of metallothionein in renal toxicity of cisplatinum</article-title>. <source>Cancer Chemother. Pharmacol.</source> <volume>40</volume>, <fpage>358</fpage>&#x2013;<lpage>362</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s002800050670</pub-id>
</citation>
</ref>
<ref id="B50">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>St. Croix</surname> <given-names>C. M.</given-names>
</name>
<name>
<surname>Wasserloos</surname> <given-names>K. J.</given-names>
</name>
<name>
<surname>Dineley</surname> <given-names>K. E.</given-names>
</name>
<name>
<surname>Reynolds</surname> <given-names>I. J.</given-names>
</name>
<name>
<surname>Levitan</surname> <given-names>E. S.</given-names>
</name>
<name>
<surname>Pitt</surname> <given-names>B. R.</given-names>
</name>
</person-group> (<year>2002</year>). <article-title>Nitric oxide-induced changes in intracellular zinc homeostasis are mediated by metallothionein/thionein</article-title>. <source>Am. J. Physiol. - Lung Cell Mol. Physiol.</source> <volume>282</volume>, <fpage>L185</fpage>&#x2013;<lpage>L192</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1152/ajplung.00267.2001</pub-id>
</citation>
</ref>
<ref id="B51">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stitt</surname> <given-names>M. S.</given-names>
</name>
<name>
<surname>Wasserloos</surname> <given-names>K. J.</given-names>
</name>
<name>
<surname>Tang</surname> <given-names>X.</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>X.</given-names>
</name>
<name>
<surname>Pitt</surname> <given-names>B. R.</given-names>
</name>
<name>
<surname>St. Croix</surname> <given-names>C. M.</given-names>
</name>
</person-group> (<year>2006</year>). <article-title>Nitric oxide-induced nuclear translocation of the metal responsive transcription factor, MTF-1 is mediated by zinc release from metallothionein</article-title>. <source>Vascul Pharmacol.</source> <volume>44</volume>, <fpage>149</fpage>&#x2013;<lpage>155</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.vph.2005.10.004</pub-id>
</citation>
</ref>
<ref id="B52">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sundar</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Chakravarty</surname> <given-names>J.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>An update on pharmacotherapy for leishmaniasis</article-title>. <source>Expert Opin. Pharmacother.</source> <volume>16</volume>, <fpage>237</fpage>&#x2013;<lpage>252</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1517/14656566.2015.973850</pub-id>
</citation>
</ref>
<ref id="B53">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>T&#xe9;llez</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Romero</surname> <given-names>I.</given-names>
</name>
<name>
<surname>Soares</surname> <given-names>M. J.</given-names>
</name>
<name>
<surname>Steindel</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Romanha</surname> <given-names>A. J.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Knockdown of host antioxidant defense genes enhances the effect of glucantime on intracellular leishmania Braziliensis in human macrophages</article-title>. <source>Antimicrob. Agents Chemother.</source> <volume>61</volume>, <fpage>e02099</fpage>&#x2013;<lpage>e02016</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/AAC.02099-16</pub-id>
</citation>
</ref>
<ref id="B54">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Thornalley</surname> <given-names>P. J.</given-names>
</name>
<name>
<surname>Va&#x161;&#xe1;k</surname> <given-names>M.</given-names>
</name>
</person-group> (<year>1985</year>). <article-title>Possible role for metallothionein in protection against radiation-induced oxidative stress. Kinetics and mechanism of its reaction with superoxide and hydroxyl radicals</article-title>. <source>Biochim. Biophys. Acta - Protein Struct. Mol. Enzymol.</source> <volume>827</volume>, <fpage>36</fpage>&#x2013;<lpage>44</lpage>. doi: <pub-id pub-id-type="doi">10.1016/0167-4838(85)90098-6</pub-id>
</citation>
</ref>
<ref id="B55">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Trapnell</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Roberts</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Goff</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Pertea</surname> <given-names>G.</given-names>
</name>
<name>
<surname>Kim</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Kelley</surname> <given-names>D. R.</given-names>
</name>
<etal/>
</person-group>. (<year>2012</year>). <article-title>Differential gene and transcript expression analysis of RNA-seq experiments with TopHat and Cufflinks</article-title>. <source>Nat. Protoc.</source> <volume>7</volume>, <fpage>562</fpage>&#x2013;<lpage>578</lpage>. doi: <pub-id pub-id-type="doi">10.1038/nprot.2012.016</pub-id>
</citation>
</ref>
<ref id="B56">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Troadec</surname> <given-names>M.-B.</given-names>
</name>
<name>
<surname>Ward</surname> <given-names>D. M.</given-names>
</name>
<name>
<surname>Lo</surname> <given-names>E.</given-names>
</name>
<name>
<surname>Kaplan</surname> <given-names>J.</given-names>
</name>
<name>
<surname>De Domenico</surname> <given-names>I.</given-names>
</name>
</person-group> (<year>2010</year>). <article-title>Induction of FPN1 transcription by MTF-1 reveals a role for ferroportin in transition metal efflux</article-title>. <source>Blood</source> <volume>116</volume>, <fpage>4657</fpage>&#x2013;<lpage>4664</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1182/blood-2010-04-278614</pub-id>
</citation>
</ref>
<ref id="B57">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Va&#x161;&#xe1;k</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Meloni</surname> <given-names>G.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>Chemistry and biology of mammalian metallothioneins</article-title>. <source>J. Biol. Inorg Chem.</source> <volume>16</volume>, <fpage>1067</fpage>&#x2013;<lpage>1078</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s00775-011-0799-2</pub-id>
</citation>
</ref>
<ref id="B58">
<citation citation-type="journal">
<person-group person-group-type="author">
<collab>WHO</collab>
</person-group> (<year>2010</year>). <article-title>Control of the leishmaniases. World health organization, geneva</article-title>. <source>Tech Rep. Ser.</source> <volume>949</volume>, <fpage>22</fpage>&#x2013;<lpage>26</lpage>.</citation>
</ref>
<ref id="B59">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhou</surname> <given-names>H.</given-names>
</name>
<name>
<surname>DeLoid</surname> <given-names>G.</given-names>
</name>
<name>
<surname>Browning</surname> <given-names>E.</given-names>
</name>
<name>
<surname>Gregory</surname> <given-names>D. J.</given-names>
</name>
<name>
<surname>Tan</surname> <given-names>F.</given-names>
</name>
<name>
<surname>Bedugnis</surname> <given-names>A. S.</given-names>
</name>
<etal/>
</person-group>. (<year>2012</year>). <article-title>Genome-Wide RNAi Screen in IFN-&#x3b3;-Treated Human Macrophages Identifies Genes Mediating Resistance to the Intracellular Pathogen Francisella tularensis Neyrolles O, ed</article-title>. <source>PloS One</source> <volume>7</volume>, <elocation-id>e31752</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1371/journal.pone.0031752</pub-id>
</citation>
</ref>
</ref-list>
</back>
</article>